Keyes Jason A — SEC Form 4 filings
SEC reporting owner CIK 1678152. 10 Form 4 filings on record with FilingPulse; latest filed 2026-08-10.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-07-18 to 2026-08-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 700 shares, $11,200 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 4 legs across 4 filings — 40,000 shares, $30,300 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
- Largest priced transaction: purchase of 700 shares @ $16.00 ($11,200) in BlossomHill Therapeutics, Inc., filed 2026-08-10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Equillium, Inc. (EQ) | Chief Financial Officer | 6 | — | 4 legs · 40,000 sh · $30,300 | 12 |
| BlossomHill Therapeutics, Inc. (BLSM) | Chief Financial Officer | 1 | 1 leg · 700 sh · $11,200 | — | 1 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | Director | 3 | — | — | 3 |
Form 4 filings — Keyes Jason A
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-10 | 4 | BlossomHill Therapeutics, Inc. (BLSM) | Purchase (P): 700 @ $16 · Grant/award (A): 56,746 (derivative) @ $0 | EDGAR |
| 2026-05-22 | 4 | ACTUATE THERAPEUTICS, INC. (ACTU) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-05-23 | 4 | ACTUATE THERAPEUTICS, INC. (ACTU) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | Equillium, Inc. (EQ) | Grant/award (A): 70,000 (derivative) · Disposition to issuer (D): 70,000 (derivative) · Grant/award (A): 90,000 (derivative) · Disposition to issuer (D): 90,000 (derivative) · Grant/award (A): 100,000 (derivative) · Disposition to issuer (D): 100,000 (derivative) · +4 more | EDGAR |
| 2025-01-24 | 4 | Equillium, Inc. (EQ) | Sale (S): 10,000 @ $0.65 | EDGAR |
| 2025-01-06 | 4 | Equillium, Inc. (EQ) | Grant/award (A): 15,000 @ $0.54 · Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2024-11-15 | 4 | Equillium, Inc. (EQ) | Sale (S): 10,000 @ $0.70 | EDGAR |
| 2024-09-27 | 4 | Equillium, Inc. (EQ) | Sale (S): 10,000 @ $0.81 | EDGAR |
| 2024-08-14 | 4 | ACTUATE THERAPEUTICS, INC. (ACTU) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-07-18 | 4 | Equillium, Inc. (EQ) | Sale (S): 10,000 @ $0.87 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1678152 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →